VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,675 | -10.6% | 508 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $15,301 | -54.0% | 508 | -50.5% | 0.00% | -50.0% |
| Q1 2023 | $33,241 | +12.9% | 1,027 | -0.1% | 0.01% | +14.3% |
| Q4 2022 | $29,450 | +17.8% | 1,028 | +1.6% | 0.01% | +16.7% |
| Q3 2022 | $25,000 | -10.7% | 1,012 | 0.0% | 0.01% | -14.3% |
| Q2 2022 | $28,000 | -28.2% | 1,012 | +0.1% | 0.01% | -22.2% |
| Q1 2022 | $39,000 | +21.9% | 1,011 | -0.1% | 0.01% | +12.5% |
| Q4 2021 | $32,000 | +6.7% | 1,012 | +0.9% | 0.01% | 0.0% |
| Q3 2021 | $30,000 | -18.9% | 1,003 | -9.1% | 0.01% | -20.0% |
| Q2 2021 | $37,000 | -82.2% | 1,103 | -61.0% | 0.01% | -83.9% |
| Q1 2021 | $208,000 | +845.5% | 2,827 | +371.2% | 0.06% | +785.7% |
| Q4 2020 | $22,000 | 0.0% | 600 | 0.0% | 0.01% | -12.5% |
| Q2 2020 | $22,000 | +57.1% | 600 | 0.0% | 0.01% | +33.3% |
| Q1 2020 | $14,000 | -96.9% | 600 | -96.2% | 0.01% | -96.9% |
| Q4 2019 | $456,000 | – | 15,585 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |